Key result
Systemic inflammation correlates with both CMD and diastolic dysfunction in women without obstructive CAD.
Why the study?
Systemic inflammation and coronary microvascular dysfunction may be causal drivers of HFpEF, but their association with non-endothelial dependent CMD and diastolic dysfunction is unclear.
Cross-Sectional (n=431)
Yes
While inflammatory biomarkers are associated with both coronary microvascular dysfunction and diastolic dysfunction, non-endothelial dependent CMD does not appear to play a major pathophysiologic role in diastolic dysfunction.
Inflammatory biomarkers link CMD and diastolic dysfunction; leaves open non-endothelial CMD's causal role in elevated filling pressures.
PURPOSE: Systemic inflammation and coronary microvascular dysfunction (CMD) may be causal drivers of heart failure with preserved ejection fraction (HFpEF). We tested the hypothesis that subclinical inflammation is associated with non-endothelial dependent CMD and diastolic dysfunction. METHODS: In a cross-sectional study of 336 women with angina but no flow limiting coronary artery stenosis (180 with diabetes) and 95 asymptomatic controls, blood samples were analysed for 90 biomarkers of which 34 were part of inflammatory pathways. CMD was assessed as coronary flow velocity reserve (CFVR) by transthoracic Doppler echocardiography and defined as CFVR<2.5. We used E/e' as an indicator of diastolic function in age-adjusted linear regressions to assess correlations between biomarkers, CFVR and diastolic function. RESULTS: CMD was found in 59% of participants whereas only 4% fulfilled strict criteria for diastolic dysfunction. Thirty-five biomarkers, 17 of them inflammatory, were negatively correlated with CFVR and 25, 15 inflammatory, were positively correlated with E/e'. A total of 13 biomarkers, 9 inflammatory, were associated with both CFVR and E/e'. CFVR and E/e' were only correlated in the subgroup of patients with CMD and signs of increased filling pressure (E/e'>10) (p = 0.012). CONCLUSION: This is the first study to link a large number of mainly inflammatory biomarkers to both CMD and E/e', thus confirming a role of inflammation in both conditions. However, despite a high prevalence of CMD, few patients had diastolic dysfunction and the data do not support a major pathophysiologic role of non-endothelial dependent CMD in diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Suhrs et al. (2020) conducted a cross-sectional in Angina with no obstructive coronary artery disease (n=431). Systemic inflammation (inflammatory biomarkers) vs. Lower levels of inflammatory biomarkers was evaluated on Correlation between 90 cardiovascular biomarkers, coronary flow velocity reserve (CFVR), and E/e' ratio. Systemic inflammation was significantly associated with both coronary microvascular dysfunction and diastolic dysfunction, as 13 biomarkers (9 inflammatory) correlated with both CFVR and E/e' in women with angina and no obstructive coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: